IL1B and COVID-19: The systemic inflammation elicited by COVID-19, increases the levels of several inflammatory molecules, including C-reactive protein, IL-1β, IL-2, IL-6, IL-8, IL-10, and TNF-α (Tay et al., 2020; Mulchandani et al., 2021).